Validation of Intrinsic Left Ventricular Assist Device Data Tracking Algorithm for Early Recognition of Centrifugal Flow Pump Thrombosis

Advanced stage heart failure patients can benefit from the unloading effects of an implantable left ventricular assist device. Despite best clinical practice, LVADs are associated with adverse events, such as pump thrombosis (PT). An adaptive algorithm alerting when an individual’s appropriate levels in pump power uptake are exceeded, such as in the case of PT, can improve therapy of patients implanted with a centrifugal LVAD. We retrospectively studied 75 patients implanted with a centrifugal LVAD in a single center. A previously optimized adaptive pump power-tracking algorithm was compared to clinical best practice and clinically available constant threshold algorithms. Algorithm performances were analyzed in a PT group (n = 16 patients with 30 PT events) and a thoroughly selected control group (n = 59 patients, 34.7 patient years of LVAD data). Comparison of the adaptive power-tracking algorithm with the best performing constant threshold algorithm resulted in sensitivity of 83.3% vs. 86.7% and specificity of 98.9% vs. 95.3%, respectively. The power-tracking algorithm produced one false positive detection every 11.6 patient years and early warnings with a median of 3.6 days prior to PT diagnosis. In conclusion, a retrospective single-center validation study with real-world patient data demonstrated advantageous application of a power-tracking algorithm into LVAD systems and clinical practice.

[1]  F. Pappalardo,et al.  Real-Time Analysis of the Log Files of the HeartWare Continuous-Flow Left Ventricular Assist Device for the Early Diagnosis of Pump Thrombosis: a Step Forward Toward Clinical Translation , 2021, Journal of Cardiovascular Translational Research.

[2]  Andrew J. Sauer,et al.  A Power Tracking Algorithm for Early Detection of Centrifugal Flow Pump Thrombosis , 2021, ASAIO journal (1992).

[3]  E. Potapov,et al.  Propensity score-based analysis of long-term follow-up in patients supported with durable centrifugal left ventricular assist devices: the EUROMACS analysis. , 2021, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[4]  H. Copeland,et al.  The Society of Thoracic Surgeons Intermacs 2020 Annual Report. , 2021, The Annals of thoracic surgery.

[5]  T. Graetz,et al.  Statistics of heart failure and mechanical circulatory support in 2020 , 2020, Annals of translational medicine.

[6]  E. Potapov,et al.  Updated definitions of adverse events for trials and registries of mechanical circulatory support: A consensus statement of the mechanical circulatory support academic research consortium. , 2020, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  D. Zimpfer,et al.  Early Detection of Pump Thrombosis in Patients With Left Ventricular Assist Device , 2020, ASAIO journal.

[8]  Jonathan S. Gordon,et al.  Clinical Implications of LDH Isoenzymes in Hemolysis and Continuous-flow Left Ventricular Assist Device-Induced Thrombosis. , 2020, Artificial organs.

[9]  D. Zimpfer,et al.  Continuous LVAD monitoring reveals high suction rates in clinically stable outpatients , 2020, Artificial organs.

[10]  D. Burkhoff,et al.  Initial experience with telemonitoring in left ventricular assist device patients. , 2019, Journal of thoracic disease.

[11]  G. Laufer,et al.  A Standardized Telephone Intervention Algorithm Improves the Survival of Ventricular Assist Device Outpatients , 2018, Artificial organs.

[12]  W. Matzek,et al.  Interventional Treatment of LVAD Outflow Graft Stenosis by Introduction of Bare Metal Stents. , 2017, ASAIO journal.

[13]  T. Schlöglhofer,et al.  International Coordinator Survey Results on the Outpatient Management of Patients with the Heartware® Ventricular Assist System , 2016, The International journal of artificial organs.

[14]  G. Couper,et al.  Thrombus around the redesigned HeartWare HVAD inflow cannula: A pathologic case series. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  Volkmar Falk,et al.  Diagnosis and Treatment Algorithm for Blood Flow Obstructions in Patients With Left Ventricular Assist Device. , 2016, Journal of the American College of Cardiology.

[16]  N. Smedira,et al.  Current risks of HeartMate II pump thrombosis: Non-parametric analysis of Interagency Registry for Mechanically Assisted Circulatory Support data. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  N. Uriel,et al.  Identification and Management of Pump Thrombus in the HeartWare Left Ventricular Assist Device System: A Novel Approach Using Log File Analysis. , 2015, JACC. Heart failure.

[18]  J. Matsuo,et al.  Synergistic Costimulatory Effect of Chlamydia pneumoniae with Carbon Nanoparticles on NLRP3 Inflammasome-Mediated Interleukin-1β Secretion in Macrophages , 2015, Infection and Immunity.

[19]  Ranjit John,et al.  Hemolysis, pump thrombus, and neurologic events in continuous-flow left ventricular assist device recipients. , 2014, The Annals of thoracic surgery.

[20]  Anne E. Dierlam,et al.  HeartWare Controller Logs A Diagnostic Tool and Clinical Management Aid for the HVAD Pump , 2014, ASAIO journal.

[21]  P. Macdonald,et al.  Interaction between physical activity and continuous-flow left ventricular assist device function in outpatients. , 2013, Journal of cardiac failure.

[22]  R. D. Alley,et al.  The society of thoracic surgeons. , 1976, The Annals of thoracic surgery.

[23]  Nader Moazami,et al.  An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.